Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
GPT HealthcareNSE:GPTHEALTH -0.90%44 EV-to-EBITDA is 13.23 as of Sep. 02, 2026, which is 5% below its 10-year median of 13.97. GuruFocus rates NSE:GPTHEALTH with a GF Score™ of 44/100. The stock has 1 warning sign investors should review. Among 515 Healthcare Providers & Services companies, GPT Healthcare ranks worse than 60.39% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, GPT Healthcare's enterprise value is ₹12,883 Mil.
GPT Healthcare's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was ₹974 Mil. Therefore, GPT Healthcare's EV-to-EBITDA for today is 13.23.
The historical rank and industry rank for GPT Healthcare's EV-to-EBITDA or its related term are showing as below:
NSE:GPTHEALTH'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 10.91 Med: 13.97 Max: 23.01
Current: 13.22
During the past 6 years, the highest EV-to-EBITDA of GPT Healthcare was 23.01. The lowest was 10.91. And the median was 13.97.
NSE:GPTHEALTH's EV-to-EBITDA is ranked worse than 60.39% of 515
companies
in the Healthcare Providers & Services industry
Industry Median: 10.43
vs NSE:GPTHEALTH: 13.22
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
GPT Healthcare's PE Ratio (TTM) for today is calculated as:
GPT Healthcare's share price for today is ₹151.63.
GPT Healthcare's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹5.760.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for GPT Healthcare's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:GPTHEALTH vs HCA, THC, EHC: EV-to-EBITDA Comparison
For the Medical Care Facilities subindustry, GPT Healthcare's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GPT Healthcare EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, GPT Healthcare's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where GPT Healthcare's EV-to-EBITDA falls into.
GPT Healthcare's current Enterprise Value is ₹12,883 Mil.
GPT Healthcare's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹974 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GPT Healthcare (NSE:GPTHEALTH) has a EV-to-EBITDA of 13.23 as of Sep. 02, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on GPT Healthcare. This is near median its historical median of 13.97. Over the past decade, GPT Healthcare's EV-to-EBITDA has ranged from 10.91 to 23.01. According to the industry distribution chart, GPT Healthcare ranks #311 out of 515 companies in the Healthcare Providers & Services industry, placing it in the top 60.4%.
Is GPT Healthcare's EV-to-EBITDA too high?
GPT Healthcare's current EV-to-EBITDA of 13.23 is near median its 10-year median of 13.97. Over the past 10 years, this metric has ranged from a low of 10.91 to a high of 23.01. The Healthcare Providers & Services industry median EV-to-EBITDA is 10.43. GPT Healthcare's value of 13.23 is 26.8% above this industry median. Based on the distribution chart, GPT Healthcare ranks #311 out of 515 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, GPT Healthcare has a GF Score™ of 44/100, reflecting its overall financial health beyond just this single metric.
How does GPT Healthcare's EV-to-EBITDA compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, GPT Healthcare ranks #311 out of 515 companies for EV-to-EBITDA. This places GPT Healthcare in the lower half of its industry. The industry median EV-to-EBITDA is 10.43. GPT Healthcare's value of 13.23 is 26.8% above this benchmark. Historically, GPT Healthcare's own EV-to-EBITDA has ranged from 10.91 to 23.01 over the past decade. While the company's 10-year median is 13.97 vs. the industry median of 10.43, GPT Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 10.43, based on 515 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. GPT Healthcare's current EV-to-EBITDA of 13.23 is 26.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on GPT Healthcare. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 10.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. GPT Healthcare's current EV-to-EBITDA is 13.23, which is near median its own 10-year median of 13.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GPT Healthcare stock overvalued right now?
GPT Healthcare (NSE:GPTHEALTH) has a current EV-to-EBITDA of 13.23. The current EV-to-EBITDA is 13.23, which is near median its 10-year median of 13.97 and 26.8% above the Healthcare Providers & Services industry median of 10.43. GPT Healthcare's overall GF Score™ is 44/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For GPT Healthcare (NSE:GPTHEALTH), the current EV-to-EBITDA is 13.23 as of Sep. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
GPT Healthcare Ltd is engaged in the healthcare sector. It operates a chain of mid-sized full-service hospitals under the ILS brand. It provides integrated healthcare services, with a focus on secondary and tertiary care and operates four multispecialty hospitals in Dum Dum, Salt Lake and Howrah in West Bengal and Agartala in Tripura with a total capacity of approximately 561 beds. It offers a comprehensive range of healthcare services across over 35 specialities and super specialities, including internal medicine and diabetology, nephrology (including renal transplants), laparoscopic and general surgery, gynaecology and obstetrics, critical care, gastroenterology, orthopaedics and joint replacements, interventional cardiology, neurology, neurosurgery, paediatrics, and neonatology.
44GF Score
Get the complete analysis for NSE:GPTHEALTH
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:GPTHEALTH has been successfully added to your 
